[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545729":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":34,"responsibleParty":50,"collaborators":19,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":19,"enrollmentInfo":62,"targetDuration":19,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":72,"overallStatus":36,"whyStopped":19,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Centre Leon Berard","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"use of myDIET tool for nutritional management","EXPERIMENTAL","Patients will be followed up at regular intervals during neoadjuvant treatment, perioperatively and up to 6 months after the date of surgery (after completion of postoperative treatment).",[13],"Other: myDIET software tool",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"myDIET software tool","The tool is based on self-questionnaires completed by the patient. They are mainly filled in using visual analogue scales (from 0-10) or grades of symptoms\u002Ftoxicities (Grades 0 to 4), based on the CTCAE V5. These scales will cover the following themes: food intake, weight changes, digestive symptoms, taste disorders, pain and fatigue. The system will be able to monitor data changes and the response given will be adapted according to the severity of symptoms:\n\n* No signs of seriousness: general prevention or treatment documents\u002Fadvice: toxicity management, nutritional advices targeted on symptoms, on digestive problems, on appropriate physical activity.\n* Presence of signs of seriousness: action to be taken and alert to the coordinating nurse, oncologist or dietician.\n\nIn case of an alert, the coordinating nurse will call the patient back and either manage the symptom, schedule a nutritional consultation to initiate nutritional management, or refer the patient to the oncologist.",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Pamela Funk-Debleds, MD","Centre Léon Berard","PRINCIPAL_INVESTIGATOR",[26,31],{"name":22,"role":27,"phone":28,"phoneExt":29,"email":30},"CONTACT","0469856020","+33","pamela.funk-debleds@lyon.unicancer.fr",{"name":32,"role":27,"phone":28,"phoneExt":29,"email":33},"Clélia Coutzac, MD","clelia.coutzac@lyon.unicancer.fr",[35],{"facility":23,"status":36,"city":37,"state":19,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Lyon","69008","France","FR",{"type":42,"coordinates":43},"Point",[44,45],4.84789,45.74906,{"lat":45,"lon":44},[48,49],{"name":22,"role":27,"phone":28,"phoneExt":29,"email":30},{"name":32,"role":27,"phone":28,"phoneExt":29,"email":33},{"type":51,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100545729","phase-2-study-evaluating-the-efficacy-of-the-mydiet-software-tool-in-the-nutritional-management-of-patients-with-localized-and-resectable-gastric-or-esogastric-junction-cancer-100545729",false,"NCT06385691","Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.","Evaluation of the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.","MyDIET","Inclusion Criteria:\n\n* Patient 18 years of age or older at date of signing informed consent to participate;\n* Histologically proven diagnosis of gastric adenocarcinoma or OGJ;\n* Localized, resectable disease;\n* Patients with an indication for perioperative chemotherapy and\u002For immunotherapy validated in multidisciplinary consultation meeting, with a scheduled surgery date at least 1 month after enrolment;\n* Performance status (ECOG): 0-2;\n* Membership of a social security scheme;\n* Signed informed consent to participate.\n\nExclusion Criteria:\n\n* Other associated solid cancer or haemopathy;\n* Presence of severe comorbidity (Charlson index \\> 9)\n* Presence of unbalanced dysthyroidism;\n* History of gastric, duodenal or esophageal surgery;\n* Inability to comply with study requirements, including :\n\n  * Impossibility for the patient or his\u002Fher caregiver to connect to myDIET;\n  * Difficulty in understanding the written French language;\n  * Psychological incapacity (e.g. excessive vulnerability, psychiatric disorder) or physical incapacity (e.g. physical\u002Fmotor disability);\n* Patient under guardianship, curatorship or safeguard of justice;\n* Patients already participating in a clinical trial or interventional study likely to interfere with the evaluation of the primary endpoint.\n* Pregnant or breast-feeding patient.","ALL","18 Years",{"count":63,"type":64},60,"ESTIMATED","INTERVENTIONAL",[67],"PHASE2","This is a prospective, single-center, single-arm Phase II study evaluating the efficacy of the myDIET software tool in the nutritional management of patients with localized and resectable esogastric junction cancer.",[70,71],"Gastric Cancer","Oesogastric Junction Cancer",[73,74,75,76,77,78],"denutrition","software tool","physical activity","postoperative treatment","chemotherapy","immunotherapy","2026-04-23",{"date":81,"type":82},"2026-04-28","ACTUAL",{"date":84,"type":82},"2024-04-26",{"date":86,"type":64},"2028-10-31",{"name":5,"class":6},1]